Table 1.
Numbers of worms recovered and percent efficacy for each treatment group. All dogs were infected with 300 A. caninum L3 on day 0, were treated on day 24, and were euthanized and worms recovered on day 34. Statistical comparisons were performed using the Wilcoxon's Rank Sum test.
Treatment Groupa | No. ofdogs | Numbers of worms per dog (range) | Geometric mean b number of worms per dog | % Efficacy c |
---|---|---|---|---|
Pyrantel pamoate | 8 | 63–105 | 74.8a | 23.2 |
Fenbendazole | 8 | 57–94 | 72.0a | 26.1 |
Milbemycin oxime | 8 | 55–115 | 88.9 | 8.8 |
Emodepside + praziquantel | 8 | 0–1 | 0.4a | 99.6 |
Non-treated control | 8 | 71–132 | 97.4 | NA |
NA: Not applicable.
Statistically significant compared to the non-treated control group (p < 0.05).
Nemex®-2 (pyrantel pamoate), Panacur® C (fenbendazole), Interceptor® (milbemycin oxime).
Worm counts were logarithmically transformed (ln [count + 1]), averaged and then back-transformed to approximate the geometric means.
Efficacy was calculated using the formula: [(geometric mean worm count control group – geometric mean worm count treated group)/(geometric mean worm count control group)] x 100.